Blue Horseshoe Stocks: PIXY Review & More

ShiftPixy, Inc. PIXY

As we were mentioning on Monday morning, we included PIXY in Friday’s report on its first ever trading day. Generally speaking we don’t tend to cast our lot in with brand new IPO’s, but a trusted source in our network gave us a heads-up on PIXY, and didn’t let us down.

We of course passed it along to our readers immediately in our premarket report on Friday, and the stock, after two trading days has made some really nice progress.

From the initial opening price of 6.30 we observed in PIXY, it went on to hit a high of 9.70 to kick off the short trading week on Monday. That marks a two-day swing of 54% for this newly-trading juggernaut. We’ll continue to be on the lookout for PIXY to keep recording higher base levels of support.


Opexa Therapeutics, Inc. OPXA

An honorable mention from Monday’s report is OPXA, especially considering that sessions just prior to a holiday break are typically low-key affairs.

The stock put up a solid intraday performance, running 35% from a low of a dollar up to 1.35, and pulling back into the close at 1.15. However, premarket activity this morning has seen the stock trade back to just below Monday’s high. This is one we’ll want to keep on our radar for the time being.


Aphria, Inc. APHQF

We’ve been familiar with APHQF for quite a time, but today will be the first occasion we’ve actually mentioned it in our reports.

Today, we wanted to point out that the company released two PR’s yesterday, the more significant of which was the announcement of a 1-year cannabis supply deal with a licensed Canadian medical provider which will bring upwards of $5M in revenue beginning midway through next year. We’ll provide links to both PR’s so you can check them out for yourself.

Aphria Inks Major Wholesale Supply Agreement With Scientus Pharma, Health Canada Licensed Dealer - 07/04

Tokyo Smoke to open Canadian flagship retail store on Queen Street West - 07/04


Extended Watchlist:
OTTV, CLSN, MSDI, MTBC, TOPS, GBR, FCEL